Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer

被引：0
|
作者：
G. Quintero-Aldana
M. Jorge
C. Grande
M. Salgado
E. Gallardo
S. Varela
C. López
M. J. Villanueva
A. Fernández
E. Alvarez
P. González
J. Castellanos
J. Casal
R. López
B. Campos Balea
机构：
[1] Hospital Universitario Lucus,
[2] Augusti,undefined
[3] Complejo Hospitalario Universitario de Vigo,undefined
[4] CHUVI,undefined
[5] Complejo Hospitalario de Ourense,undefined
[6] CHOU,undefined
[7] Complejo Hospitalario Universitario de Santiago,undefined
[8] CHUS,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Advanced gastric cancer; Cisplatin; Combination chemotherapy; Docetaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：731 / 737
页数：6
相关论文
共 50 条
  • [1] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [2] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
    Kunisaki, Chikara
    Takahashi, Masazumi
    Makino, Hirochika
    Oshima, Takashi
    Fujii, Shoichi
    Takagawa, Ryo
    Kimura, Jun
    Kosaka, Takashi
    Ono, Hidetaka A.
    Akiyama, Hirotoshi
    Kameda, Kunio
    Kito, Fumihiko
    Morita, Satoshi
    Endo, Itaru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1363 - 1368
  • [4] Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
    Chikara Kunisaki
    Masazumi Takahashi
    Hirochika Makino
    Takashi Oshima
    Shoichi Fujii
    Ryo Takagawa
    Jun Kimura
    Takashi Kosaka
    Hidetaka A. Ono
    Hirotoshi Akiyama
    Kunio Kameda
    Fumihiko Kito
    Satoshi Morita
    Itaru Endo
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1363 - 1368
  • [5] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [6] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [7] Phase II study of docetaxel, cisplatin, and 5-fluorouracil (TPF) as first-line chemotherapy in advanced gastric cancer
    Chowdhury, Q.
    Hossain, S.
    Reza, S.
    Hai, M. A.
    Faruqui, M.
    Morshed, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [9] Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer
    Vasey, PA
    Paul, J
    Birt, A
    Junor, EJ
    Reed, NS
    Symonds, RP
    Atkinson, R
    Graham, J
    Crawford, SM
    Coleman, R
    Thomas, H
    Davis, J
    Eggleton, SPH
    Kaye, SB
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2069 - 2080
  • [10] BIWEEKLY COMBINATION CHEMOTHERAPY OF DOCETAXEL, IRINOTECAN AND CISPLATIN AS SECOND-LINE TREATMENT FOR ADVANCED GASTRIC CANCER
    Denda, T.
    Sudo, K.
    Nakamura, K.
    Hara, T.
    Yamaguchi, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
12345